Tech Company Financing Transactions
Syntach Funding Round
invested in a $18.9 million funding round for Syntach. The round was recorded on 1/31/2023.
Transaction Overview
Company Name
Announced On
1/31/2023
Transaction Type
Venture Equity
Amount
$18,940,000
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
The company intends to use the funds to develop the Syntach Cardiac Support System, a device for patients with heart failure.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Traktorvägen 6C
Lund, SE-226 60
SE
Lund, SE-226 60
SE
Phone
Website
Email Address
Overview
Syntach AB is a Swedish innovation-driven company based in Lund, which has close links and extensive cooperation with various institutions at the University of Lund. The company was founded with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. Since many patients needing cardiac support also suffer from mitral valve regurgitation, (a leaking mitral valve), the company is also developing a minimally-invasive device to correct this to be used in combination with the cardiac support device, or on a stand-alone basis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tor Peters
Chief Executive Officer
Jan Solem
Browse more venture capital transactions:
Prev: 1/31/2023: Convey911 venture capital transaction
Next: 1/31/2023: Fibery venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs